Market Insights Health Hospitals Inpatient Care

Treatment of Musculoskeletal Diseases - Germany

Germany

Germany is projected to experience significant growth in the Treatment of Musculoskeletal Diseases market.
The revenue in this market is estimated to reach €12.60bn in 2024.
Moreover, it is expected to exhibit a steady annual growth rate (CAGR 2024-2029) of 2.69%, leading to a market volume of €14.39bn by 2029.
When compared globally, in the United States is anticipated to generate the highest revenue in this market, with €56,370.00m projected for 2024.
Germany is leading the way in innovative treatments for musculoskeletal diseases, with a strong focus on research and development.

Key regions: United States, United Kingdom, Europe, Brazil, Germany

Mercado

Región

Comparación de regiones

Moneda

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.